Management of pre eclampsia

3,879 views 22 slides Jan 22, 2018
Slide 1
Slide 1 of 22
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22

About This Presentation

very useful to know about the pre eclampsia


Slide Content

MANAGEMENT OF PRE-
ECLAMPSIA

PREGNANCY
INDUCED
HYPERTENSION
Hypertension develops
as a direct result of
gravid state

GESTATIONAL
HYPERTENSION
A sustained raise of blood
pressure to 140/90mmHg or
more in two different
occasions 4 or more hours
apart beyond 20
th
week of
pregnancy or during first 24
hours of delivery in a
previously normotensive
woman

PRE-ECLAMPSIA
development of
hypertension-141/90
with proteinuria
after 20
th
week of
pregnancy
in previously
normotensive non
proteinuric patient

RISK FACTORS
Primigravidae
Family history
Placental abnormalities
New paternity
Thrombophilias
Pre-existing vascular
disease
Genetic
Immunologic

CLINICAL FEATURES
PEDAL OEDEMA

ALARMING SYMPTOMS
Headache
Sleep disturbance
Diminished urinary
output
Epigastric pain
Blurring or diminished
vision

Diagnostic
criteria
Hypertension
140/90
Oedema
Proteinuria

MANAGEMENT
Hospitalization
Rest
Diet-100gm protein, usual salt
intake, no fluid restriction, total
calorie 1600cal/day.
Sedatives
Antihypertensives

ANTIHYPERTENSIVES
Methyldopa
Labetalol
Propranalol
Hydralazine
Nifidipine

Methyldopa
250mg oral
250-500mg infusion
Watch for postural hypotension
Do investigation to identify the
hemolytic anemia
Avoid working with sharp
instruments and driving as the drug
will induce sleep

Labetalol
Orally-100mg t.i.d
1-2mg/min IV infusion.
Do the liver function test
periodically.

Hydralazine
100mg/4
th
hourly-orally
Watch for maternal
hypotension, tachycardia,
arrhythmia, palpitation.
Watch for sodium
retention.

Nifidipine
5-10mg-orally-t.i.d.
Resume to small activities.
Watch for hypotension.
Help the patient to get up from
the bed.
Use cautiously if there is any
possibility of using the MgSO4

Anticonvulsan
t therapy

Pritchard regime for the
antenatal management of
severe PIH

Zuspan regime for
antenatal management of
severe PIH

Magnesium sulfate
Vasodilation there by
reducing cerebral
ischemia
Magnesium sulfate is
now recommended drug
of choice for routine
anticonvulsant
management of
eclampsia.

Stop magnesium
sulfate if
Respiratory rate <
16/min
Urine output < 25 ml/h
Knee jerks are
sluggish / absent

If magnesium
toxicity is
suspected
Suggested by the
absence of reflexes
1 g IV of calcium
gluconate is given

Nurse`s
Responsibility
Hourly monitoring of deep
tendon reflexes
Hourly monitoring of
respiratory status and
oxygen saturation and it
should remain >14/mt and
>95% respectively.
Ensure availability of
calcium gluconate the
antidote of magnesium
toxicity
Tags